Literature DB >> 6970154

In vitro and in vivo analysis of the PABA test compared with the Lundh test--influence of intraluminal pH.

F J Hoek, G T Sanders, A Teunen, G N Tijtgat.   

Abstract

Lundh test and PABA test results were compared in 50 patients. In the resulting correlation curve three areas of interest were differentiated: (1) an area with mean tryptic activity, found in the Lundh test, below 4 U/ml, where an abnormal PABA test result was also seen; (2) an intermediate area from 4 to 9 U/ml, where PABA test results may be found in discordance with the Lundh test; (3) the normal level, where PABA excretion was shown to be independent of intestinal chymotrypsin activity. In experiments in vitro on the kinetics of the hydrolysis of BTPABA by chymotrypsin the profound influence of the pH on Km and Vmax was shown. This influence of the pH explains why in the intermediate area of pancreatic dysfunction normal PABA test results were found in a number of cases. A higher mean pH level of the Lundh test aspirates was found for patients with a normal PABA test result than for patients with an abnormal PABA test.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6970154      PMCID: PMC1419314          DOI: 10.1136/gut.22.1.8

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  15 in total

1.  [Diagnosis of exocrine pancreatic malfunction with a synthetic peptide specific for chymotrypsine (author's transl)].

Authors:  W Bornschein; F L Goldmann; J Dressler
Journal:  Klin Wochenschr       Date:  1978-02-15

2.  A method for the assay of chymotrypsin in crude biological materials.

Authors:  A R Imondi; R P Stradley; E R Butler; R L Wolgemuth
Journal:  Anal Biochem       Date:  1973-07       Impact factor: 3.365

3.  Diagnosis of exocrine pancreatic insufficiency in cystic fibrosis by the synthetic peptide N-benzoyl-L-tyrosyl-p-aminobenzoic acid.

Authors:  S Nousia-Arvanitakis; C Arvanitakis; N Desai; N J Greenberger
Journal:  J Pediatr       Date:  1978-05       Impact factor: 4.406

4.  PABA screening test for exocrine pancreatic function in infants and children.

Authors:  M Sacher; A Kobsa; D H Shmerling
Journal:  Arch Dis Child       Date:  1978-08       Impact factor: 3.791

5.  Diagnosis of pancreatic disease by a synthetic peptide. A new test of exocrine pancreatic function.

Authors:  C Arvanitakis; N J Greenberger
Journal:  Lancet       Date:  1976-03-27       Impact factor: 79.321

6.  Measurement of tryptic activity in intestinal juice as a diagnostic test of pancreatic disease.

Authors:  H B Cook; J E Lennard-Jones; S M Sherif; H S Wiggins
Journal:  Gut       Date:  1967-08       Impact factor: 23.059

7.  Oral administration of a chymotrypsin-labile peptide--a new test of exocrine pancreatic function in man (PFT).

Authors:  K Gyr; G A Stalder; I Schiffmann; C Fehr; D Vonderschmitt; H Fahrlaender
Journal:  Gut       Date:  1976-01       Impact factor: 23.059

8.  [PABA test versus chymotrypsin and fat determinations in the stool in pancreatic functional diagnosis].

Authors:  H Bühler; R Ammann
Journal:  Schweiz Med Wochenschr       Date:  1979-04-21

9.  [Exocrine pancreatic function test by N-benzoyl-L-tyrosyl-p-aminobenzoic acid (author's transl)].

Authors:  R Thienhaus; C Niederau
Journal:  Z Gastroenterol       Date:  1979-03       Impact factor: 2.000

10.  Synthetic peptides in the diagnosis of exocrine pancreatic insufficiency in animals.

Authors:  A R Imondi; R P Stradley; R Wolgemuth
Journal:  Gut       Date:  1972-09       Impact factor: 23.059

View more
  7 in total

1.  BT-PABA test with plasma PABA measurements: evaluation of sensitivity and specificity.

Authors:  J C Delchier; J C Soule
Journal:  Gut       Date:  1983-04       Impact factor: 23.059

2.  Optimum dose of bentiromide.

Authors:  A R Imondi
Journal:  Dig Dis Sci       Date:  1983-09       Impact factor: 3.199

3.  Comparison of the oral (PABA) pancreatic function test, the secretin-pancreozymin test and endoscopic retrograde pancreatography in chronic alcohol induced pancreatitis.

Authors:  A S Mee; A H Girdwood; E Walker; N H Gilinsky; R E Kottler; I N Marks
Journal:  Gut       Date:  1985-11       Impact factor: 23.059

4.  Serum PABA and fluorescein in the course of Bz-Ty-PABA and pancreolauryl test as an index of exocrine pancreatic insufficiency.

Authors:  G Cavallini; W Piubello; G Brocco; R Micciolo; G Chech; G Angelini; L Benini; A Riela; L Dalle Molle; I Vantini
Journal:  Dig Dis Sci       Date:  1985-07       Impact factor: 3.199

5.  Improved specificity of the PABA test with p-aminosalicylic acid (PAS).

Authors:  F J Hoek; F A van den Bergh; J T Klein Elhorst; J L Meijer; E Timmer; G N Tytgat
Journal:  Gut       Date:  1987-04       Impact factor: 23.059

6.  Comparative study of pancreatic polypeptide (PP) secretion, endocrine and exocrine function, and structural damage in chronic alcohol induced pancreatitis (CAIP).

Authors:  A S Mee; L J Klaff; A H Girdwood; M Paul; M Tyler; I N Marks
Journal:  Gut       Date:  1983-07       Impact factor: 23.059

7.  Diagnostic and therapeutic applications of bentiromide screening test for exocrine pancreatic insufficiency in patients with cystic fibrosis. Comparison with other tests of exocrine pancreatic disease.

Authors:  V S Hubbard; R O Wolf; L A Lester; A C Egge
Journal:  Dig Dis Sci       Date:  1984-10       Impact factor: 3.199

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.